Literature DB >> 27440898

To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.

Michaela Weber-Gerlach1, Friedemann Weber2.   

Abstract

The nonstructural protein NS1 is well established as a virulence factor of influenza A virus counteracting induction of the antiviral type I interferon system. Recent studies now show that viral structural proteins, their derivatives, and even the genome itself also contribute to keeping the host defense under control. Here, we summarize the current knowledge on these NS1-independent interferon escape strategies.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27440898      PMCID： PMC5021431          DOI： 10.1128/JVI.00041-16

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  62 in total

1.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

2.  A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Authors:  Shih-Feng Hsu; Wen-Chi Su; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection.

Authors:  Christian Wisskirchen; Thomas H Ludersdorfer; Dominik A Müller; Eva Moritz; Jovan Pavlovic
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus.

Authors:  Asiel A Benitez; Maryline Panis; Jia Xue; Andrew Varble; Jaehee V Shim; Amy L Frick; Carolina B López; David Sachs; Benjamin R tenOever
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

5.  Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49.

Authors:  Christian Wisskirchen; Thomas H Ludersdorfer; Dominik A Müller; Eva Moritz; Jovan Pavlovic
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

Review 6.  Mx GTPases: dynamin-like antiviral machines of innate immunity.

Authors:  Otto Haller; Peter Staeheli; Martin Schwemmle; Georg Kochs
Journal:  Trends Microbiol       Date:  2015-01-06       Impact factor: 17.079

7.  Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.

Authors:  Jan Dittmann; Silke Stertz; Daniel Grimm; John Steel; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 8.  Host genetics of severe influenza: from mouse Mx1 to human IRF7.

Authors:  Michael J Ciancanelli; Laurent Abel; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2016-01-04       Impact factor: 7.486

9.  The 3' untranslated regions of influenza genomic sequences are 5'PPP-independent ligands for RIG-I.

Authors:  William G Davis; J Bradford Bowzard; Suresh D Sharma; Mayim E Wiens; Priya Ranjan; Shivaprakash Gangappa; Olga Stuchlik; Jan Pohl; Ruben O Donis; Jacqueline M Katz; Craig E Cameron; Takashi Fujita; Suryaprakash Sambhara
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

10.  The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm.

Authors:  Han Xiao; Marian J Killip; Peter Staeheli; Richard E Randall; David Jackson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103
View more
  6 in total

1.  pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.

Authors:  Thomas Gerlach; Luca Hensen; Tatyana Matrosovich; Janina Bergmann; Michael Winkler; Christin Peteranderl; Hans-Dieter Klenk; Friedemann Weber; Susanne Herold; Stefan Pöhlmann; Mikhail Matrosovich
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

Review 2.  The Contribution of Viral Proteins to the Synergy of Influenza and Bacterial Co-Infection.

Authors:  Miriam Mikušová; Karolína Tomčíková; Katarína Briestenská; František Kostolanský; Eva Varečková
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818

Review 3.  Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments.

Authors:  Katharina S Schulz; Karen L Mossman
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

4.  The C-Terminal Effector Domain of Non-Structural Protein 1 of Influenza A Virus Blocks IFN-β Production by Targeting TNF Receptor-Associated Factor 3.

Authors:  Wei Qian; Xiaoqin Wei; Kelei Guo; Yongtao Li; Xian Lin; Zhong Zou; Hongbo Zhou; Meilin Jin
Journal:  Front Immunol       Date:  2017-07-03       Impact factor: 7.561

Review 5.  Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.

Authors:  Jian Zheng; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2017-11-21       Impact factor: 7.090

Review 6.  Innate Immune Evasion by Human Respiratory RNA Viruses.

Authors:  Marjolein Kikkert
Journal:  J Innate Immun       Date:  2019-10-14       Impact factor: 7.349
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.